|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/439 | (2006.01) |
| A61K 9/0048 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 9/0043 | (2013.01) | ||
| A61K 31/4427 | (2006.01) | ||
| A61K 31/439 | (2013.01) | ||
| A61K 31/4985 | (2006.01) | ||
| A61K 31/4995 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4427 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 31/4985 | (2013.01) | ||
| A61P 11/02 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/4995 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 38/13 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 38/13 | (2013.01) | ||
| A61K 31/436 | (2013.01) |
| (11) | Number of the document | 3848028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20212556.3 |
| Date of filing the European patent application | 2015-10-19 | |
| (97) | Date of publication of the European application | 2021-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462066280 P | 2014-10-20 | US | |
| 201562100844 P | 2015-01-07 | US |
| (72) |
ACKERMANN, Douglas Michael, Jr. , US
LOUDIN, James , US
MANDELL, Kenneth J. , US
|
| (73) |
Oyster Point Pharma, Inc. ,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | METHODS OF TREATING OCULAR CONDITIONS |
| METHODS OF TREATING OCULAR CONDITIONS |